Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Ductal Adenocarcinoma 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Hyperphagia 1Hematologic Neoplasms 1Glioblastoma 1Emergencies 1Critical Illness 1Carcinoma, Renal Cell 1

Interventions

Standard of Care 5Specimen Handling 4Practice Guidelines as Topic 4Methods 4Educational Status 3Early Intervention, Educational 3Cyclophosphamide 3Sentinel Lymph Node Biopsy 2Paclitaxel 2Magnetic Resonance Imaging 2Interviews as Topic 2Genetic Counseling 2Exercise 2Drug Therapy 2Diet Therapy 2veliparib 1toripalimab 1sacituzumab govitecan 1pegfilgrastim 1olaparib 1Vorinostat 1Videotape Recording 1Tablets 1Surveys and Questionnaires 1STA 9090 1Restore polishing paste 1Resistance Training 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Triple Negative Breast Neoplasms × Glucose × Clear all
NCT03457779 2021-10-08

Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer

Baylor Research Institute

Phase NA Completed
16 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡